This protocol is judged by an institutional overview board, an impartial team that evaluations any clinical trials involving individuals. If a review will involve a Program I drug, as soon as the board approves the protocol as moral, the scientists really have to submit an application for an investigational new drug (IND) quantity in the FDA.Togeth